GL1X · GenesisL1 explorer

Research workbench

Crystal structure of cblc (mmachc) (1-238), a human B12 processing enzyme, complexed with an antivitamin B12

Analyse Crystal structure of cblc (mmachc) (1-238), a human B12 processing enzyme… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5UOS
Type
protein
Length
239 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Methylmalonic aciduria and homocystinuria type C protein
EC
1.16.1.-
UniProt
Q9Y4U1
Ligands
B12, 8FS, GSH, 171, NA, SO4
Pockets
1 · best druggability 0.58

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMethylmalonic aciduria and homocystinuria type C protein (EC 1.16.1.-)protein23940% helix, 17% strandQ9Y4U1

Ligands and binding sites

  • B12 · Cobalamin · ligand · chains A
  • 8FS · 1-ethynyl-2,4-difluorobenzene · ligand
  • GSH · Glutathione · ligand · chains A
  • 171 · 2-phenylamino-ethanesulfonic acid · ligand · chains A
  • NA · Sodium ion · metal
  • SO4 · Sulfate ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13910.580.7541B12, GSH

Compared structures

  • 5UOS · Crystal Structure of CblC (MMACHC) (1-238), a human B12 processing enzyme, complexed with… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9Y4U1 · AlphaFold monomer V2.0 prediction for cyanocobalamin reductase / alkylcobalamin… · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.